Drug Profile
Research programme: PPAR gamma agonists - SK biopharmaceuticals
Alternative Names: YKP4183; YKP4283Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator SK Holdings
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA
- 28 Sep 2011 Preclinical development is ongoing
- 21 Feb 2007 Preclinical development is ongoing